fda semaglutide warning november 2025 compounding February 17, 2026: Pennsylvania compounding pharmacy earns another FDA warning letter – Partnership for Safe Medicines U.S. FDA finds no evidence

Even that small a percentage point is significant, however, and the industry is right to be keeping an eye on it

Cleveland Clinic researchers have found that a well-known diabetes drug may also be able to help reduce the risk of cardiovascular events in certain individuals

Do cravings come back

Through telehealth, patients in Florida can receive complete evaluations and prescriptions without in-person visits

Our coaching also includes practical nutrition guidance, with a special focus on maintaining protein intake and lifestyle adjustments that support lasting results

Rybelsus side effects The most common side effects of Rybelsus are: Nausea Stomach pain Diarrhea Poor appetite Vomiting Constipation Although rare, some people taking Rybelsus may experience serious side effects: Severe allergic reaction Kidney problems Gallbladder problems Low blood sugar (hypoglycemia) Pancreatitis (inflammation of the pancreas) Diabetic retinopathy in patients with Type 2 Diabetes Thyroid tumors, including medullary thyroid carcinoma, a rare but serious condition Warnings Rybelsus has a black box warning from the FDA for the risk of thyroid tumors or thyroid cancer